Physician profile

Cindy Pham

Endocrinology, Diabetes & Metabolism · Los Angeles, CA

NPI 1720498561

$768.57

in general payments reported to CMS, 2019-2025

13 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$18.43

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic Minimed, INC. $287.41 2019-2020
Lilly USA, LLC $129.25 2019-2021
Sanofi-Aventis U.S. LLC $67.04 2020
Amgen INC. $55.30 2019-2020
Corcept Therapeutics $51.49 2020-2021
Novo Nordisk INC $44.26 2020-2021
Alexion Pharmaceuticals, INC. $30.59 2019
Antares Pharma, INC. $18.63 2019
Sanofi Pasteur INC. $18.43 2023
Lifescan, INC. $17.17 2020
Pfizer INC. $16.54 2019
Zealand Pharma US, INC. $16.35 2021
Medtronic, INC. $16.11 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cindy Pham

$768.57

in general payments reported 2019-2025

Years
2019-2023
Top company
Medtronic Minimed, INC.

https://glasscript.com/doctor/4218892/cindy-pham

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.